Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 1/20 | 0.57 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.52 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.51 |
| ▸ | F2 | P00734 | 1/20 | 0.51 |
| ▸ | CALCR | P30988 | 2/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29802631 | 0.94 | SLC6A2 (0.60) | SLC6A2OPRM1OPRD1 | |
| SCHEMBL30692437 | 0.88 | REN (0.51) | SLC6A2F2 | |
| SCHEMBL32665679 | 0.88 | SLC6A2 (0.51) | SLC6A2OPRM1OPRD1F2CALCR | |
| SCHEMBL30233222 | 0.87 | CALCR (0.62) | OPRM1OPRD1F2CALCR | |
| SCHEMBL30512510 | 0.86 | CALCR (0.51) | F2CALCR | |
| SCHEMBL29448041 | 0.86 | SLC6A2 (0.65) | SLC6A2OPRM1OPRD1 | |
| SCHEMBL31583875 | 0.85 | NMUR2 (0.54) | SLC6A2F2 | |
| SCHEMBL30011313 | 0.85 | CCKBR (0.56) | OPRM1 | |
| SCHEMBL30495776 | 0.85 | F2 (0.59) | SLC6A2OPRM1OPRD1F2CALCR | |
| SCHEMBL30729666 | 0.85 | SLC6A2 (0.52) | SLC6A2OPRM1OPRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119751581-A | Cyclic peptide molecule of specific targeting EphA2 and application thereof in preparation of tumor diagnosis reagent or tumor treatment drug | 上海交通大学 | 2025-04-04 | — | — | CN | claimed |
| CN-119751581-A | Cyclic peptide molecule of specific targeting EphA2 and application thereof in preparation of tumor diagnosis reagent or tumor treatment drug | 上海交通大学 | 2025-04-04 | — | — | CN | disclosed |